UNITE4TB webinar: Rolling out of new drugs without diagnostic capacities

Date

04 October 2022

Place

Online

This 1-hour webinar will be chaired by Raquel Duarte & Christoph Lange, with Daniela Cirillo and Richard Menzies as speakers. It will take place on the 4th of October (14:00 – 15:00 CEST).

Registration is free through the link below and open to all.

For non-members of the European Respiratory Society (ERS), all that is needed is to create a myERS profile, which can be done for free and in just a few minutes, in order to then register for the webinar.

https://www.ersnet.org/events/rolling-out-of-new-drugs-without-diagnostic-capacities/

Abstract:

The last few years have seen unprecedented progress in shortening the treatment for both drug-sensitive and drug-resistant tuberculosis. Several new drugs and regimens have been discovered (or repurposed) for improved treatment, but they roll out without companion diagnostic tools, which may jeopardize the efficacy of these regimens in the long run. There are still many unanswered questions that have not been adequately addressed and weak evidence to support them.

UNITE4TB aims to set a new standard for anti-TB regimen development, by upgrading current clinical trial methodology and enhancing the efficiency with which new regimes are delivered. “Rolling out of New Drugs without Diagnostic Capacities” is the fourth webinar of a series from the UNITE4TB project, where the speakers – Prof. Daniella Cirillo and Dr. Richard Menzies will provide an open space for discussion on the progress of shorter treatment regimes for TB, whilst providing a space for reflection on the current evidence gap, as well as the future possibilities in this field. This Debate will be divided into 2 parts: first the presentation by the speakers; followed by a discussion moderated by Prof. Dr. Raquel Duarte and Prof. Dr. Cristoph Lange.